BackgroundCheck.run
Search For

Corey Lee Strickland, 55825 Newmans Ln, Martinsville, NJ 08836

Known as:
Corey O Strickland Corey L Strickland Corey Ohman
Related to:
Bruce D Wallace 58

Corey Strickland Phones & Addresses

825 Newmans Ln, Martinsville, NJ 08836    610-3272693   

375 North Ave, North Plainfield, NJ 07060    908-4121415   

Gainesville, FL   

Kenilworth, NJ   

Pottstown, PA   

Ithaca, NY   

Royersford, PA   

825 Newmans Ln, Martinsville, NJ 08836   

Work

Company: Canteen compass Nov 2013 Position: Cook/utility worker/stocker

Education

School / High School: Chester High School- Chester, PA 2004 Specialities: High School Diploma in Music

Skills

Hospitality • Restaurant • Customer service • Entertainment
Get Report
Control this profile

Mentions for Corey Lee Strickland

Corey Strickland resumes & CV records

Resumes

Corey Strickland Photo 45

Hairstylist

Work:

Hairstylist
Corey Strickland Photo 46

Corey Strickland

Corey Strickland Photo 47

Corey Strickland

Location:
United States
Corey Strickland Photo 48

Corey Strickland - Chester, PA

Work:
Canteen Compass Nov 2013 to 2000
Cook/Utility worker/stocker Valley Forge Casino - King of Prussia, PA May 2014 to Jan 2015
Steward Walmart - Boothwyn, PA Jul 2013 to Jan 2014
Grocery Stock Martin's Run living Care - Media, PA Apr 2013 to Jun 2013
Cold Preparation Harrah's Philadelphia Casino - Chester, PA May 2009 to Feb 2013
Steward ( Promotion From Bus Boy) Kmart - Brookhaven, PA Oct 2008 to Jun 2009
Electronic Associate Harrah's Chester Casino - Chester, PA Jan 2007 to Apr 2009
Bus Boy Burger King - Brookhaven, PA Oct 2006 to Dec 2006
Crew Member/Cook
Education:
Chester High School - Chester, PA 2004 to 2008
High School Diploma in Music
Skills:
Hospitality,Restaurant, Customer service, Entertainment

Publications & IP owners

Us Patents

Crystalline Farnesyl Protein Transferase Compositions And Methods For Use

US Patent:
6535820, Mar 18, 2003
Filed:
Aug 26, 1999
Appl. No.:
09/383364
Inventors:
Corey Strickland - North Plainfield NJ
Patricia C. Weber - Yardley PA
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
G01N 3348
US Classification:
702 19, 435193, 424 945, 530350, 514 2, 514 12
Abstract:
The present invention relates to crystalline compositions comprising farnesyl protein transferase-like polypeptides in complex with substrates and inhibitors. Also disclosed are crystallization conditions for these compositions and their use for structural determination of FPT:FPP/FPP analog: peptide/inhibitor complexes.

Crystallizable Farnesyl Protein Transferase Compositions, Crystals Thereby Obtained, And Methods For Use

US Patent:
6539309, Mar 25, 2003
Filed:
Jul 29, 1999
Appl. No.:
09/364182
Inventors:
Corey Strickland - North Plainfield NJ
Zhen Wu - Edison NJ
William T. Windsor - East Brunswick NJ
Patricia C. Weber - Yardley PA
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
G01N 3348
US Classification:
702 19, 435193, 424 945, 530350, 514 2, 514 12
Abstract:
The present invention relates to compositions and crystals of farnesyl protein transferase and farnesyl protein transferase in complex with substrates and inhibitors. Also disclosed are crystallization conditions for these compositions and their use for structural determination of FPT:FPP/FPP analog:peptide/inhibitor complexes.

Treatment Of Malaria With Farnesyl Protein Transferase Inhibitors

US Patent:
6645966, Nov 11, 2003
Filed:
Jan 18, 2002
Appl. No.:
10/053335
Inventors:
William T. Windsor - East Brunswick NJ
Patricia C. Weber - Yardley PA
Corey O. Strickland - Martinsville NJ
Michael Gelb - Seattle WA
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 31495
US Classification:
51425303, 514311, 514895
Abstract:
Disclosed is a method of treating Malaria comprising administering an effective amount of an FPT inhibitor to a patient in need of such treatment alone or in combination with an additional antimalarial agent and/or agent for reversing antimalarial resistance. Also disclosed are novel Farnesyl Protein Transferase inhibitors.

Farnesyl Protein Transferase Inhibitors

US Patent:
6800636, Oct 5, 2004
Filed:
Dec 20, 2001
Appl. No.:
10/028251
Inventors:
Timothy Guzi - Chatham NJ
Dinanath F. Rane - Morganville NJ
Alan K. Mallams - Hackettstown NJ
Alan B. Cooper - West Caldwell NJ
Ronald J. Doll - Maplewood NJ
Viyyoor M. Girijavallabhan - Parsippany NJ
Arthur G. Taveras - Denville NJ
Corey Strickland - North Plainfield NJ
Joseph M. Kelly - Parlin NJ
Jianping Chao - Summit NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 314545
US Classification:
514290, 514325, 51425302, 51421705, 5142282, 5142328, 514218, 546 93, 546195, 546203, 540544, 540598, 540575, 544 60, 544121, 544361, 544370, 544360
Abstract:
Disclosed are compounds of the formula: wherein R represents a cyclic moiety to which is bound an imodazolylalkyl group; R represents a carbamate, urea, amide or sulfonamide group; and the remaining substituents are as defined herein. Also disclosed is a method of treating cancer and a method of inhibiting farnesyl protein transferase using the disclosed compounds.

Modified Tumor Necrosis Factor-Alpha Converting Enzyme And Methods Of Use Thereof

US Patent:
7138264, Nov 21, 2006
Filed:
May 21, 2003
Appl. No.:
10/444257
Inventors:
Brian M. Beyer - Lincroft NJ, US
Richard N. Ingram - Scotch Plains NJ, US
Peter Orth - New York City NY, US
Corey Strickland - Martinsville NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C12N 9/64
C12N 5/10
C12Q 1/37
A01N 37/18
A61K 38/00
US Classification:
435226, 435219, 435 23, 435325, 4352523, 514 2, 530300
Abstract:
The present invention discloses a modified tumor necrosis factor-alpha converting enzyme (TACE) catalytic domain, that unlike the native TACE catalytic domain, is stable at high protein concentrations. The present invention further discloses methods for generating crystals of the modified TACE protein in protein-ligand complexes with a number of inhibitors. In addition, the present invention discloses methods of using the proteins, crystals and/or three-dimensional structures obtained to identify compounds that can modulate the enzymatic activity of TACE.

Codon-Optimized Β-Secretase And Methods Of Refolding And Processing

US Patent:
7166454, Jan 23, 2007
Filed:
May 22, 2003
Appl. No.:
10/443949
Inventors:
Brian M. Beyer - Lincroft NJ, US
Bruce A. Malcolm - Westfield NJ, US
Corey O. Strickland - Martinsville NJ, US
Wenyan Wang - Edison NJ, US
Eileen Wilson - Raritan NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C12N 9/48
C12N 15/00
C12N 1/20
C12N 1/14
C12N 5/10
C12N 5/00
C07H 21/04
US Classification:
435212, 536 232, 4353201, 4352523, 43525411, 435419, 435325, 43525233
Abstract:
The present application relates to methods for growing crystals of both the uncomplexed and complexed forms of β-secretase (BACE) polypeptide. Polypeptides used herein are derived from human BACE which is also known by the synonyms “mamapsin 2”, “human β-site APP-cleaving enzyme, and Asp2”. The present application also relates to crystalline forms of uncomplexed BACE and the three-dimensional structure of BACE, as determined from the crystals. In addition, the present application relates to the use of crystalline forms of BACE to identify ligands, preferably inhibitors (antagonists), which bind to, and preferably inhibit the enzymatic activity of, BACE. Furthermore, the present application relates to nucleic acid sequences encoding BACE polypeptide, and methods for making BACE in greater quantity than prior methods, resulting in more effective crystallization.

Methods For Identifying Modified Tumor Necrosis Factor-Alpha Converting Enzyme Inhibitors

US Patent:
7529628, May 5, 2009
Filed:
Oct 18, 2006
Appl. No.:
11/582710
Inventors:
Brian M. Beyer - Lincroft NJ, US
Richard N. Ingram - Scotch Plains NJ, US
Peter Orth - New York NY, US
Corey O. Strickland - Martinsville NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
G01N 33/48
G06G 7/58
US Classification:
702 19, 703 11
Abstract:
The present invention discloses a modified tumor necrosis factor-alpha converting enzyme (TACE) catalytic domain, that unlike the native TACE catalytic domain, is stable at high protein concentrations. The present invention further discloses methods for generating crystals of the modified TACE protein in protein-ligand complexes with a number of inhibitors. In addition, the present invention discloses methods of using the proteins, crystals and/or three-dimensional structures obtained to identify compounds that can modulate the enzymatic activity of TACE.

Method For Making Β-Secretase Co-Crystals Complexed With A Ligand

US Patent:
7569391, Aug 4, 2009
Filed:
Dec 6, 2006
Appl. No.:
11/634737
Inventors:
Brian M. Beyer - Lincroft NJ, US
Bruce A. Malcolm - Paoli PA, US
Corey O. Strickland - Martinsville NJ, US
Wenyan Wang - Edison NJ, US
Eileen Wilson - Raritan NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
G01N 31/00
G01N 33/00
US Classification:
436 4, 435183, 117927
Abstract:
The present application relates to methods for growing crystals of both the uncomplexed and complexed forms of β-secretase (BACE) polypeptide. The present application also relates to crystalline forms of uncomplexed BACE and the three-dimensional structure of BACE, as determined from the crystals. In addition, the present application relates to the use of crystalline forms of BACE to identify ligands, preferably inhibitors (antagonists), which bind to, and preferably inhibit the enzymatic activity of, BACE. Furthermore, the present application relates to nucleic acid sequences encoding human BACE polypeptide, and methods for making BACE in greater quantity than prior methods, resulting in more effective crystallization.

Possible Relatives

Cynthia S Strickland  David C Strickland  Cyros T Strickland  Dean Strickland  Deanna L Strickland  Dale C Strickland  Dearl J Strickland  Corey F Johnson  Corey D Johnston  Corey R Stanfield 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.